{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:17:43Z","timestamp":1767665863113},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[1992,6,1]],"date-time":"1992-06-01T00:00:00Z","timestamp":707356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1992,6]]},"DOI":"10.1007\/bf02245152","type":"journal-article","created":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T15:38:36Z","timestamp":1133451516000},"page":"303-309","source":"Crossref","is-referenced-by-count":49,"title":["A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine"],"prefix":"10.1007","volume":"107","author":[{"given":"D. J.","family":"Heal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. T. J.","family":"Frankland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gosden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. J.","family":"Hutchins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"Prow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. P.","family":"Luscombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. R.","family":"Buckett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02245152_CR1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00428409","volume":"85","author":"RD Blitzer","year":"1985","unstructured":"Blitzer RD, Becker RE (1985) Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism. Psychopharmacology 85:173\u2013177","journal-title":"Psychopharmacology"},{"key":"BF02245152_CR2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.2042-7158.1977.tb11370.x","volume":"29","author":"C Braestrup","year":"1977","unstructured":"Braestrup C (1977) Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats. J Pharm Pharmacol 29:463\u2013470","journal-title":"J Pharm Pharmacol"},{"key":"BF02245152_CR3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0278-5846(88)90003-6","volume":"12","author":"WR Buckett","year":"1988","unstructured":"Buckett WR, Thomas PC, Luscombe GP (1988) The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation. Prog Neuropsychopharmacol Biol Psychiatry 12:575\u2013584","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF02245152_CR4","unstructured":"Cheetham SC, Viggers JA, Slater NA, Buckett WR (1990) Inhibition of [3H]paroxetine binding by sibutramine, its metabolites and other antidepressants correlates with inhibition of [3H]5-hydroxytryptamine uptake. Br J Pharmacol 101:515P"},{"key":"BF02245152_CR5","first-page":"127","volume":"215","author":"BR Cooper","year":"1980","unstructured":"Cooper BR, Hester TJ, Maxwell RA (1980) Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther 215:127\u2013134","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245152_CR6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(78)90207-8","volume":"52","author":"AM Giulio Di","year":"1978","unstructured":"Di Giulio AM, Groppetti A, Cattabeni F, Galli CL, Maggi A, Algeri S, Ponzio F (1978) Significance of dopamine metabolites in the evaluation of drugs acting on dopaminergic neurons. Eur J Pharmacol 52:201\u2013207","journal-title":"Eur J Pharmacol"},{"key":"BF02245152_CR7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.2042-7158.1978.tb13201.x","volume":"30","author":"RW Fuller","year":"1978","unstructured":"Fuller RW, Perry KW, Bymaster FP, Wong DT (1978) Comparative effects of pemoline, amfonelic acid and amphetamine on dopamine uptake and release in vitro and on brain 3,4-dihydroxyphenylacetic acid concentration in spiperone-treated rats. J Pharm Pharmacol 30:197\u2013199","journal-title":"J Pharm Pharmacol"},{"key":"BF02245152_CR8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1471-4159.1989.tb07389.x","volume":"53","author":"DJ Heal","year":"1989","unstructured":"Heal DJ, Butler SA, Hurst EM, Buckett WR (1989) Antidepressant treatments, including sibutramine hydrochloride and electro-convulsive shock, decrease\u03b2 1-but not\u03b2 2-adrenoceptors in rat cortex. J Neurochem 53:1019\u20131025","journal-title":"J Neurochem"},{"key":"BF02245152_CR9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0028-3908(90)90038-S","volume":"29","author":"DJ Heal","year":"1990","unstructured":"Heal DJ, Frankland ATJ, Buckett WR (1990) A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detection. Studies with drugs which alter dopamine metabolism in the brain. Neuropharmacology 29:1141\u20131150","journal-title":"Neuropharmacology"},{"key":"BF02245152_CR10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02244212","volume":"103","author":"DJ Heal","year":"1991","unstructured":"Heal DJ, Prow MR, Buckett WR (1991) Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic\u03b1 2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride. Psychopharmacology 103:251\u2013257","journal-title":"Psychopharmacology"},{"key":"BF02245152_CR11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00431964","volume":"67","author":"CN Jones","year":"1980","unstructured":"Jones CN, Howard JL, McBennett ST (1980) Stimulus properties of antidepressants in the rat. Psychopharmacology 67:111\u2013118","journal-title":"Psychopharmacology"},{"key":"BF02245152_CR12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-2999(79)90411-4","volume":"54","author":"RW Kerwin","year":"1979","unstructured":"Kerwin RW, Pycock CJ (1979) Specific stimulating effect of glycine on [3H]-dopamine efflux from substantia nigra slices of the rat. Eur J Pharmacol 54:93\u201398","journal-title":"Eur J Pharmacol"},{"key":"BF02245152_CR13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0028-3908(89)90048-8","volume":"28","author":"GP Luscombe","year":"1989","unstructured":"Luscombe GP, Hopcroft RH, Thomas PC, Buckett WR (1989) The contribution of metabolites to the rapid and potent down-regulation of rat cortical\u03b2-adrenoceptors by the putative antidepressant sibutramine hydrochloride. Neuropharmacology 28:129\u2013134","journal-title":"Neuropharmacology"},{"key":"BF02245152_CR14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02244604","volume":"100","author":"GP Luscombe","year":"1990","unstructured":"Luscombe GP, Slater NA, Lyons MB, Wynne RD, Scheinbaum ML, Buckett WR (1990) Effect on radiolabelled-monoamine uptake in vitro of plasma taken from healthy volunteers administered the antidepressant sibutramine HCl. Psychopharmacology 100:345\u2013349","journal-title":"Psychopharmacology"},{"key":"BF02245152_CR15","unstructured":"Martin KF, Phillips I, Cheetham SC, Heal DJ, Buckett WR (1990) Only antidepressants with marked effects on central dopamine function decrease rat striatal D2 receptor number. Br J Pharmacol 100:405P"},{"key":"BF02245152_CR16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0091-3057(86)90413-2","volume":"24","author":"JA Nielsen","year":"1986","unstructured":"Nielsen JA, Shannon NJ, Bero L, Moore KE (1986) Effects of acute and chronic bupropion on locomotor activity and dopaminergic neurons. Pharmacol Biochem Behav 24:795\u2013799","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245152_CR17","volume-title":"A stereotaxic atlas of the rat brain","author":"LJ Pellegrino","year":"1979","unstructured":"Pellegrino LJ, Pellegrino AS, Cushman AS (1979) A stereotaxic atlas of the rat brain, 2nd edn. Plenum Press, New York","edition":"2nd edn."},{"key":"BF02245152_CR18","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.1981.tb00573.x","volume":"36","author":"F Ponzio","year":"1981","unstructured":"Ponzio F, Achilli G, Algeri S (1981) A rapid and simple method for the determination of picogram levels of 3-methoxytyramine in brain tissue using liquid chromatography with electrochemical detection. J Neurochem 36:1361\u20131367","journal-title":"J Neurochem"},{"key":"BF02245152_CR19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(75)90239-3","volume":"34","author":"M Raiteri","year":"1975","unstructured":"Raiteri M, Bertollini A, Angelini F, Levi G (1975)d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. Eur J Pharmacol 34:189\u2013195","journal-title":"Eur J Pharmacol"},{"key":"BF02245152_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0024-3205(79)90126-7","volume":"24","author":"SB Ross","year":"1979","unstructured":"Ross SB (1979) The central stimulatory action of inhibitors of the dopamine uptake. Life Sci 24:159\u2013168","journal-title":"Life Sci"},{"key":"BF02245152_CR21","first-page":"125","volume":"120","author":"B Rubin","year":"1957","unstructured":"Rubin B, Malone MH, Waugh MH, Burke JC (1957) Bioassay ofRauwolfia roots and alkaloids. J Pharmacol Exp Ther 120:125\u2013136","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245152_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(71)90121-X","volume":"14","author":"J Scheel-Kr\u00fcger","year":"1971","unstructured":"Scheel-Kr\u00fcger J (1971) Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. Eur J Pharmacol 14:47\u201359","journal-title":"Eur J Pharmacol"},{"key":"BF02245152_CR23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.2042-7158.1977.tb11460.x","volume":"29","author":"FE Soroko","year":"1977","unstructured":"Soroko FE, Mehta NB, Maxwell RA, Ferris RM, Schroeder DH (1977) Bupropion hydrochloride ((\u00b1)\u03b1-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent. J Pharm Pharmacol 29:767\u2013770","journal-title":"J Pharm Pharmacol"},{"key":"BF02245152_CR24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-201X.1971.tb10999.x","volume":"367","author":"U Ungerstedt","year":"1971","unstructured":"Ungerstedt U (1971) Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol Scand Suppl 367:49\u201367","journal-title":"Acta Physiol Scand Suppl"},{"key":"BF02245152_CR25","first-page":"542","volume":"184","author":"PF Voigtlander Von","year":"1973","unstructured":"Von Voigtlander PF, Moore KE (1973) Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine. J Pharmacol Exp Ther 184:542\u2013552","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245152_CR26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1471-4159.1982.tb08685.x","volume":"38","author":"BHC Westerink","year":"1982","unstructured":"Westerink BHC, Spaan SJ (1982) On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain. J Neurochem 38:680\u2013685","journal-title":"J Neurochem"},{"key":"BF02245152_CR27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2307\/2556164","volume":"28","author":"DA Williams","year":"1972","unstructured":"Williams DA (1972) The comparison of several dose levels with a zero dose control. Biometrics 28:519\u2013531","journal-title":"Biometrics"},{"key":"BF02245152_CR28","first-page":"163","volume":"40","author":"PL Wood","year":"1988","unstructured":"Wood PL, Altar CA (1988) Dopamine release in vivo from nigrostriatal, mesolimbic and mesocortical neurons: utility of 3-methoxytyramine measurements. Pharmacol Rev 40:163\u2013187","journal-title":"Pharmacol Rev"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02245152\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T17:33:15Z","timestamp":1557941595000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02245152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,6]]},"references-count":28,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[1992,6]]}},"alternative-id":["BF02245152"],"URL":"https:\/\/doi.org\/10.1007\/bf02245152","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,6]]}}}